Epitope mapping of therapeutic Abs in healthy donors as a tool of prediction of immunogenicity

Dr. Bernard Maillere summarizes data from the Abrisk consortium. He shows that predicted epitopes from the T cell-based assays and mass spec antigen presenation assays weere consisten with epitopes detected in patients, while in silico analysis was overpredictive.